mRNA instability elements in the human papillomavirus type 16 L2 coding region

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1504-1515

  Sokolowski, Marcus ^a,b   Tan, Wei ^a,c   Jellne, Marianne ^a   Schwartz, Stefan ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; NUCLEOTIDE;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; VIRUS CAPSID; WART VIRUS;

EID: 0031883264     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1504-1515.1998     Document Type: Article

References (72)

1. Afonia, E., M. Neumann, and G. N. Pavlakis. 1997. Preferential binding of poly(A)-binding protein 1 to an inhibitory RNA element in the human immunodeficiency virus type 1 gag mRNA. J. Biol. Chem. 272:2307-2311.
2. Belasco, J. G., and G. Brawerman (ed.). 1993. Control of messenger RNA stability. Academic Press, Inc., San Diego, Calif.
3. Bellman, C. A., and R. Parker. 1995. Degradation of mRNA in eucaryotes. Cell 81:179-183.
4. Bernstein, P. L., D. J. Herrick, R. D. Prokipcak, and J. Ross. 1992. Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev. 6:642-654.
5. Billakanti, S. R., C. E. Calef, A. D. Farmer, A. L. Halpern, and G. L. Myers. 1996. Human papillomaviruses: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, N.Mex.
6. Brewer, G., and J. Ross. 1988. Poly(A) shortening and degradation of the 3′ A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol. Cell. Biol. 8:1697-1708.
7. Caponigro, G., and R. Parker. 1996. mRNA turnover in yeast promoted by the MATalpha1 instability element. Nucleic Acids Res. 24:4304-4312.
8. Caron, J. M., A. L. Jones, L. B. Rall, and M. W. Kirshner. 1985. Autoregulation of tubulin synthesis in enucleated cells. Nature (London) 317:645-651.
9. Chen, C.-Y. A., and A.-B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
10. Chen, C.-Y. A., Y. You, and A.-B. Shyu. 1992. Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability. Mol. Cell. Biol. 12:5748-5757.
11. Chow, L. T., and T. R. Broker. 1994. Papillomavirus DNA replication. Intervirology 37:150-158.
12. Churchill, M. J., J. L. Moore, M. Rosenberg, and D. W. Brighty. 1996. The rev-responsive element negatively regulates human immunodeficiency virus type 1 mRNA expression in primate cells. J. Virol. 70:5786-5790.
13. Cleveland, D. W., and J. C. Havercroft. 1983. Is apparent autoregulatory control of tubulin synthesis nontranscriptionally regulated? J. Biol. Chem. 97:919-924.
14. Cleveland, D. W., M. A. Lopata, P. Sherline, and M. W. Kirschner. 1981. Unpolymerized tubulin modulates the level of tubulin mRNAs. Cell 25:537-546.
15. Cleveland, D. W., M. F. Pittenger, and J. R. Feramisco. 1983. Elevation of tubulin levels by microinjcction suppresses new tubulin synthesis. Nature (London) 305:738-740.
16. Cochrane, A. W., K. S. Jones, S. Beidas, P. J. Dillon, A. M. Skalka, and C. Rosen. 1991. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65:5305-5313.
17. Danos, O., M. Katinka, and M. Yaniv. 1982. Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J. 1:231-236.
18. Dillner, L., P. Heino, J. Moreno-Lopez, and J. Dillner. 1991. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses. J. Virol. 65:6862-6871.
19. Fisher, C., M. R. Byers, M. J. Iadarola, and E. A. Powers. 1991. Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization. Development 111:253-258.
20. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
21. Furth, P. A., W.-T. Choe, J. H. Rex, J. C. Byrne, and C. C. Baker. 1995. Sequences homologous to 5′ splice sites are required for the inhibitory activity of papillomavirus late 3′ untranslated regions. Mol. Cell. Biol. 14: 5278-5289.
22. Graham, F. J., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-460.
23. Hagensee, M. E., and D. A. Galloway. 1996. Growing human papillomaviruses and virus-like particles in the laboratory, p. 85-92. In C. Lacey (ed.), Papillomavirus reviews: current research on papillomaviruses. Leeds University Press, Leeds, England.
24. Halpern, A., A. Farmer, and C. Calef. 1996. A survey of papillomavirus variants, p. i43-i185. In G. Myers (ed.), Human papillomaviruses, 1996. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos. N.Mex.
25. Heino, P., J. Dillner, and S. Schwartz. 1995. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus like particles. Virology 214:349-359.
26. Hennigan, A. N., and A. Jacobson. 1996. Functional mapping of the translation-dependent instability element of yeast MATα1 mRNA. Mol. Cell. Biol. 16:3833-3843.
27. Herrick, D. J., and J. Ross. 1994. The half-life of c-myc mRNA in growing and serum-stimulated cells: influence of the coding and 3′ untranslated regions and role of ribosome translocation. Mol. Cell. Biol. 14:2119-2128.
28. Howley, P. M. 1996. Papillomavirinae: the viruses and their replication, p. 2045-2076. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields' virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
29. Kennedy, I. M., J. K. Haddow, and J. B. Clements. 1990. Analysis of human papillomavirus type 16 late mRNA 3′ processing signals in vitro and in vivo. J. Virol. 64:1825-1829.
30. Kennedy, I. M., J. K. Haddow, and J. B. Clements. 1991. A negative regulatory clement in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65:2093-2097.
31. Koeller, D. M., J. A. Horowitz, J. L. Casey, R. D. Klausner, and J. B. Harford. 1991. Translation and the stability of mRNAs encoding the transferrin receptor and c-fos. Proc. Natl. Acad. Sci. USA 88:7778-7782.
32. Laimins, L. A. 1993. The biology of human papillomaviruses: from warts to cancer. Infect. Agents Dis. 2:74-86.
33. Lambert, P. F. 1991. Papillomavirus DNA replication. J. Virol. 65:3417-3420.
34. Maldarelli, F., M. A. Martin, and K. Strebel. 1991. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65:5732-5743.
35. Meyers, C., and L. A. Laimins. 1996. In vitro model systems for the study of HPV induced neoplasias, p. 79-83. In C. Lacey (ed.), Papillomavirus reviews: current research on papillomaviruses. Leeds University Press, Leeds, England.
36. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
37. Nasioulas, G., A. S. Zolotukhin, C. Tabernero, L. Solomin, C. P. Cunningham, G. N. Pavlakis, and B. K. Felber. 1994. Elements distinct from the human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J. Virol. 68:2986-2993.
38. Pittenger, M. F., and D. W, Cleveland. 1985. Retention of autoregulatory control of tubulin synthesis in cytoplasts; demonstration of a cytoplasmic mechanism that regulates the level of tubulin expression. J. Cell Biol. 101: 1941-1952.
39. Prokipcak, R. D., D. J. Herrick, and J. Ross. 1994. Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA. J. Biol. Chem. 269:9261-9269.
40. Ross, J. 1996. Control of messenger RNA stability in higher eucaryotes. Trends Biochem Sci. 12:171-176.
41. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:15-95.
42. Sachs, A. B. 1993. Messenger RNA degradation in eucaryotes. Cell 74:413-421.
43. Saiga, A., S. Orita, N. Minoura-Tada, M. Maeda, Y. Aono, M. Asakawa, K. Nakahara, R. Kubota, M. Osame, and H. Igarashi. 1997. cis-Acting inhibitory elements within the pol-env region of human T-cell leukemia virus type 1 possibly involved in viral persistence. J. Virol. 71:4485-4494.
44. Scheper, W., D. Meinsma, P. E. Holthuizen, and J. S. Sussenbach. 1995. Long-range RNA interaction of two sequence elements required for endonucleolytic cleavage of human insulin-like growth factor II mRNAs. Mol. Cell. Biol. 15:235-245.
45. Schiavi, S. C., C. L. Wellington, A.-B. Shyu, C.-Y. A. Chen, M. E. Greenberg, and J. G. Belasco. 1994. Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translation J. Biol. Chem. 269:3441-3448.
46. Schneider, R., M. Campbell, G. Nasioulas, B. K. Felber, and G. N. Pavlakis. 1997. Inactivation of human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J. Virol. 71:4892-4903.
47. Schwartz, S., M. Campbell, G. Nasioulas, J. Harrison, B. K. Felber, and G. N. Pavlakis. 1992. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:7176-7182.
48. Schwartz, S., B. K. Felber, D. M. Benko, E. M. Fenyö, and G. N. Pavlakis. 1990. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64:2519-2529.
49. Schwartz, S., B. K. Felber, E. M. Fenyö, and G. N. Pavlakis. 1990. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J. Virol. 64:5448-5456.
50. Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1992. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66:150-159.
51. Seedorf, K., G. Krämer, M. Dürst, S. Suhai, and W. G. Röwekamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
52. Seiki, M., A. Hikikoshi, and M. Yoshida. 1990. The U5 sequence is a cis-acting repressive element for genomic RNA expression of human T cell leukemia virus type 1. Virology 186:81-86.
53. Shah, K. V., and P. M. Howley. 1996. Papillomaviruses, p. 2077-2109. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields' virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
54. Shyu, A.-B., J. G. Belasco, and M. E. Greenberg. 1991. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev. 5:221-231.
55. Shyu, A.-B., M. E. Greenberg, and J. G. Belasco. 1989. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3:60-72.
56. Stanley, M. A. 1994. Replication of human papillomaviruses in cell culture. Antivir. Res. 24:1-15.
57. Taichman, L. B., and R. F. LaPorta. 1987. The expression of papillomaviruses in epithelial cells, p. 109-139. In N. P. Salzman and P. M. Howley (ed.), The papovaviridae. Plenum Press, New York, N.Y.
58. Tan, W., B. K. Felber, A. S. Zolotukhin, G. N. Pavlakis, and S. Schwartz. 1995. Efficient expression of human papillomavirus type 16 L1 protein in epithelial cells by using rev and the rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J. Virol. 69:5607-5620.
59. Tan, W., M. Schalling, C. Zhao, M. Luukkonen, M. Nilsson, E. M. Fenyö, G. N. Pavlakis, and S. Schwartz. 1996. Inhibitory activity of the equine infectious anemia virus major 5′ splice site in the absence of Rev. J. Virol. 70:3645-3658.
60. Tan, W., and S. Schwartz. 1995. The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′ untranslated region. J. Virol. 69: 2932-2945.
61. Turek, L. P. 1994. The structure, function and regulation of papillomaviral genes in infection and cervical cancer. Adv. Virus Res. 44:305-356.
62. Wellington, C. L., M. E. Greenberg, and J. G. Belasco. 1993. The destabilizing elements in the coding region of c-fos mRNA are recognized as RNA. Mol. Cell. Biol. 13:5034-5042.
63. Wisdom, R., and W. Lee. 1991. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5:232-243.
64. Wisdom, R., and W. Lee. 1990. Translation of c-myc mRNA is required for its posttranscriptional regulation during myogenesis. J. Biol. Chem. 265: 19015-19021.
65. Yeilding, N. M., M. T. Rehman, and W. M. F. Lee. 1996. Identification of sequences in c-myc mRNA that regulate its steady-state levels. Mol. Cell. Biol. 16:3511-3522.
66. Yen, T. J., D. A. Gay, J. S. Pachter, and D. W. Cleveland. 1988. Autoregulated changes in stability of polyribosome-bound β-tubulin mRNA are specified by the first 13 translated nucleotides. Mol. Cell. Biol. 8:1224-1235.
67. Yen, T. J., P. S. Machlin, and D. W. Cleveland. 1988. Autoregulated instability of β-tubulin mRNAs by recognition of the nascent amino terminus of β-tubulin. Nature (London) 334:580-585.
68. Zhao, C., W. Tan, M. Sokolowski, and S. Schwartz. 1996. Identification of nuclear and cytoplasmic factors that interact specifically with an AU-rich, cis-acting inhibitory sequence in the 3‰ untranslated region of human papillomavirus type 1 late mRNAs. J. Virol. 70:3659-3667.
69. Zhou, J., X. Y. Sun, K. Louis, and I. H. Frazer. 1994. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. J. Virol. 68:619-625.
70. zur Hausen, H. 1996. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta 1288:55-78.
71. zur Hausen, H. 1991. Viruses in human cancers. Science 254:1167-1173.
72. zur Hausen, H., and E.-M. de Villiers. 1994. Human papillomaviruses. Annu. Rev. Microbiol. 48:427-447.